(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
最近の投稿
- 1
Top Frozen yogurt Flavor: Cast Your Vote! - 2I watched the buzzy new AI documentary — and left feeling both hopeful and terrified
- 35 State of the art Advancements in Computer generated Simulation
- 4Opening Monetary Information: Your Exhaustive Manual for Finding out about Individual budget
- 5Young Muslims in Germany feel left out of Mideast debate, experts say
- Some are walking out. Some are shouting. Some are oblivious. How kids are reacting to THAT 'Wicked: For Good' scene
- Women take pride in Holy Week roles after a Spanish Catholic brotherhood's procession excluded them
- Step by step instructions to Contrast Lab Precious stones and Normal Jewels
- I asked ChatGPT who would win a Golden Globes. Here's what it got right — and totally wrong.
- Paul Feig loves a plot twist. Why not reboot 'Die Hard' starring a woman?
- Eleven Creations And Developments That Steered History
- 6 Well known Nissan Vehicles in the U.S.
- Find the Captivating Professional flowerbeds of the US
- Interstellar comet 3I/ATLAS to pass closest to Earth on Friday
